Latest Blog Posts from The Washington Service

Re-Assessing EBS CEO Kramer's Recent Planned Sales

Emergent BioSolutions Inc. (EBS) CEO and President Robert Kramer has been in the news recently due to the company's issues related to the production of the Coronavirus vaccine. In light of recent developments, we re-assess Kramer's planned selling from earlier this year.

March 2021 144 Market Report

March 2021 144 Market Report - outlining the current Form 144 brokerage market. 

Cookie Notice

This website uses cookies to improve your browsing experience and the functionality of the site. To find out more, please read our cookie policy and our terms of service. (Learn More)

Accept Cookies

Back to top